ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
GenSight’s LHON drug fails to meet endpoint in Phase III trial
February 19, 2019French gene therapy company GenSight has announced its GS010 drug indicated for eye condition Leber Hereditary Optic Neuropathy (LHON) failed to meet the primary endpoint at week 48 of a Phase III trial..... -
GenSight rebuilds its case for LHON gene therapy, eyeing filing next year
December 26, 2018GenSight Biologics has reported new data from its phase 3 program for GS010, its gene therapy for an ultrarare eye disease, sparking another uptick in its share price....
Pharma Sources Insight January 2025
